Growth Metrics

Gilead Sciences (GILD) Shareholder's Equity Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.40%
Dec 31, 2025 4.50%
Sep 30, 2025 4.28%
Jun 30, 2025 1.55%
Mar 31, 2025 -2.97%
Dec 31, 2024 -3.20%
Sep 30, 2024 -2.37%
Jun 30, 2024 -4.37%
Mar 31, 2024 -4.60%
Dec 31, 2023 1.10%
Sep 30, 2023 -0.67%
Jun 30, 2023 -0.60%
Mar 31, 2023 0.28%
Dec 31, 2022 0.68%
Sep 30, 2022 -3.25%
Jun 30, 2022 -2.63%
Mar 31, 2022 -0.52%
Dec 31, 2021 1.70%
Sep 30, 2021 4.94%
Jun 30, 2021 4.11%
Mar 31, 2021 6.23%
Dec 31, 2020 -0.95%
Sep 30, 2020 0.07%
Jun 30, 2020 1.75%
Mar 31, 2020 5.24%
Dec 31, 2019 7.44%
Sep 30, 2019 8.39%
Jun 30, 2019 6.73%
Mar 31, 2019 10.54%
Dec 31, 2018 12.89%
Sep 30, 2018 16.15%
Jun 30, 2018 14.40%
Mar 31, 2018 14.72%
Dec 31, 2017 16.52%
Sep 30, 2017 23.63%
Jun 30, 2017 23.61%
Mar 31, 2017 22.82%
Dec 31, 2016 23.04%
Sep 30, 2016 22.03%
Jun 30, 2016 21.66%
Mar 31, 2016 17.82%
Dec 31, 2015 25.57%
Sep 30, 2015 25.00%
Mar 31, 2015 18.02%
Dec 31, 2014 19.45%
Sep 30, 2014 19.68%
Jun 30, 2014 25.33%